Ad is loading...
PGRRX
Price
$50.44
Change
+$0.68 (+1.37%)
Updated
Nov 22 closing price
RPTIX
Price
$113.98
Change
+$1.08 (+0.96%)
Updated
Nov 22 closing price
Ad is loading...

PGRRX vs RPTIX

Header iconPGRRX vs RPTIX Comparison
Open Charts PGRRX vs RPTIXBanner chart's image
Pioneer Select Mid Cap Growth R
Price$50.44
Change+$0.68 (+1.37%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$113.98
Change+$1.08 (+0.96%)
VolumeN/A
CapitalizationN/A
PGRRX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGRRX vs. RPTIX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRRX is a Buy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.8B vs. PGRRX (1.59B). RPTIX pays higher dividends than PGRRX: RPTIX (0.18) vs PGRRX (0.00). PGRRX was incepted earlier than RPTIX: PGRRX (31 years) vs RPTIX (9 years). PGRRX is a more actively managed with annual turnover of: 72.00 vs. RPTIX (21.70). PGRRX has a lower initial minimum investment than RPTIX: PGRRX (0) vs RPTIX (500000). PGRRX annual gain was more profitable for investors over the last year : 41.37 vs. RPTIX (16.26). PGRRX return over 5 years is better than : 19.58 vs. RPTIX (17.97).
PGRRXRPTIXPGRRX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years9 years-
Gain YTD30.10113.696220%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B31.8B5%
Annual Yield % from dividends0.000.18-
Returns for 1 year41.3716.26254%
Returns for 3 years-9.77-12.1980%
Returns for 5 years19.5817.97109%
Returns for 10 years39.38N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CORT57.541.62
+2.90%
Corcept Therapeutics
XPEL45.730.88
+1.96%
XPEL
MCO480.663.59
+0.75%
Moody's Corp
ORGO4.050.03
+0.75%
Organogenesis Holdings
ELTX4.93-0.19
-3.71%
Elicio Therapeutics